Tadalafil Tablet
Product Images NDC 43547-049

This appears to be a table displaying the standing and supine diastolic and systolic blood pressure readings over time. There is not enough context to determine the purpose or significance of the data.*

The text pertains to a clinical study evaluating the effects of tadalafil and doxazosin on systolic blood pressure. The study involves four different treatment groups consisting of different doses of tadalafil and placebo, all of which are administered at different times. The text shows a table with the systolic blood pressure measurement and treatment groups. It does not provide any further information regarding the study or its results.*

This text provides information about the results of a study comparing the effectiveness of Tadalafil tablets 5mg and a placebo on the IPSS Total Score. The graph displays changes from the baseline score over 12 weeks of treatment. The results show that Tadalafil tablets 5mg had a significant effect compared to the placebo.*

The text is a chart or graph that compares the effectiveness of Tadalafil tablets 5 mg versus a placebo over the course of 12 weeks of treatment. The chart indicates that Tadalafil tablets are significantly more effective than the placebo.*

The text appears to be a graph showing the effects of Tadalafil tablets at a dosage of 5 mg compared to a placebo, with statistical significance indicated by "*p<0.01". However, the graph is not visible, so no further information can be provided.*

This is a medication with a usual dosage that can be found in the accompanying literature. Each tablet contains 25g of tacrolimus USP. There are warnings on the label that the medication must be kept out of reach of children, and should be dispensed in a tight container. The patient information can be accessed online. The medication is manufactured by Zhejiang Huahai Pharmaceutical in China and distributed by Soko Healthcare US, LLC in NJ, USA. The tablets should not be split and the entire dose should be taken. There are 30 tablets in the package, and it should be stored at 20°C to 25°C.*

This is a label for Tadalafil tablets containing 5 mg of tadalafil per tablet. The usual dosage is available in accompanying literature. The tablets must be kept in a tight container and stored at temperatures between 20°C to 25°C (58°F to 77°F). The medication is manufactured by Zhejiang Huahai Pharmaceutical Co in China and distributed by Soko Healthcare US. The tablets should not be split and the entire dose should be taken. The label warns of the medication being kept out of reach of children. Additionally, the impaired text contains a message regarding printing instructions available at wwasolconealtncare.com/medguideftadalafi-tablets-4.*

This is a medication called Tadalal in the form of tablets. Each tablet contains 20mg of the medication. The manufacturer is Znefang Huahai Pharmaceutical Co, Ltd. It should be stored in a tight container at a temperature range of 20°C to 25°C (68°F 0.85°F). The medication should be kept out of reach of children. There is a warning to not split the tablets and the entire dose should be taken. The usual dosage information is not available as it mentions to refer to the accompanying teraure for dosage. There is a website mentioned (wi olcohealthcare commedguidadalat-abits 4 pat) for obtaining patient information. It is distributed in the USA by S0lo Healthcare US, LLG in New Jersey.*